foravirumab foravirumab foravirumab is a monoclonal antibody for the prophylaxis of rabies. it is under development by sanofi/crucell. foravirumabmonoclonal antibodytypewhole antibodysourcehumantargetrabies virus glycoproteinclinical dataatc codenoneidentifierscas number944548-38-3 nchemspidernoneunii377vy97v7schemblchembl1743021 nchemical and physical dataformulac6400h9914n1718o1998s44molar mass144304.38 g·mol−1 ny (what is this?) (verify)